Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.370
+0.110 (4.87%)
At close: Nov 4, 2024, 4:00 PM
2.320
-0.050 (-2.11%)
After-hours: Nov 4, 2024, 6:03 PM EST
Mangoceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Market Capitalization | 6 | 6 | - | - |
Enterprise Value | 5 | 5 | - | - |
Last Close Price | 2.37 | 4.15 | - | - |
PE Ratio | - | -0.48 | - | - |
PS Ratio | 3.86 | 7.96 | - | - |
PB Ratio | 0.33 | 7.52 | - | - |
P/FCF Ratio | -1.47 | -0.83 | - | - |
P/OCF Ratio | -1.47 | -0.83 | - | - |
EV/Sales Ratio | 6.23 | 6.47 | - | - |
EV/EBITDA Ratio | -1.06 | -0.58 | - | - |
EV/EBIT Ratio | -1.05 | -0.58 | - | - |
EV/FCF Ratio | -1.50 | -0.68 | - | - |
Debt / Equity Ratio | 0.02 | 0.17 | 0.57 | -2.35 |
Debt / FCF Ratio | -0.05 | -0.02 | -0.25 | -0.56 |
Asset Turnover | 0.09 | 0.71 | 0.02 | - |
Quick Ratio | 0.36 | 3.50 | 2.62 | 0.57 |
Current Ratio | 0.38 | 3.88 | 2.67 | 0.57 |
Return on Equity (ROE) | -108.44% | -1326.69% | -669.02% | - |
Return on Assets (ROA) | -57.51% | -494.04% | -242.68% | - |
Return on Capital (ROIC) | -61.70% | -542.58% | -251.60% | - |
Earnings Yield | -162.70% | -158.13% | - | - |
FCF Yield | -106.56% | -120.17% | - | - |
Buyback Yield / Dilution | -55.07% | -49.22% | -34.98% | - |
Total Shareholder Return | -55.07% | -49.22% | -34.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.